Prostate cancer screening--time to abandon one-size-fits-all approach?
Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX 77030, USA. jekim@mdanderson.org
Jeri
J
Kim
John W
JW
Davis
D026683:Advisory Committees; D000368:Aged; D023281:Genomics / Q000639:trends; D017408:Guidelines as Topic; D006291:Health Policy; D006801:Humans; D019458:Insurance Coverage; D008017:Life Expectancy; D008297:Male; D008403:Mass Screening / Q000191:economics / Q000592:standards*; D008875:Middle Aged; D057240:Patient Preference; D011157:Population Dynamics; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology; D040901:Proteomics / Q000639:trends; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D018570:Risk Assessment; D014481:United States; D019564:Unnecessary Procedures
D017430:Prostate-Specific Antigen